Investing Ideas
/
Brazilian Healthcare Undervalued over 20% based on DCF

Brazilian Healthcare Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

2 companies

Hapvida Participações e Investimentos

Market Cap: R$6.0b

Operates in the healthcare sector in Brazil.

HAPV3

R$12.65

7.9%

-61.0%

Diagnósticos da América

Market Cap: R$4.1b

Provides diagnostic and hospital services in Brazil and Argentina.

DASA3

R$3.25

2.2%

80.6%